Replies to post #3611 on Galectin Therapeutics Inc. (GALT)

[Amatuer17]

Agree - they are ahead of everyone in terms NASH-CX - literally no one is near where they are - no drug with P3 ready and good safety and P2 results.

Question of starting the P3 trial and/or convincing BP about their product so they collaborate or buy them out.

These trials are very long - long period of enrollment and min 48 weeks for efficacy - with many other companies, GLMD, MDGL, VKTX, GILD starting P2/P3 trials, NASH patients have high demand - it is very competitive. I would rather have some BP buy this co, let me make money even if not huge and move on.